Pre-natal diagnosis is a dubious disease in the field of genetic metabolism, clinical performance is complex and often involves multi-system fatigue. Early identification and standardized diagnosis are essential for improving prognosis. Diagnosis of the disease requires a combination of clinical performance, imaging inspections, laboratory tests and pathological checkups.
The platform can assist in matching teams of authoritative experts at home and abroad to provide accurate diagnosis and treatment programs. Treatment and management of pre-natal diagnosis of pre-natal cataracts require individualized development, usually including multidimensional management, including drug therapy, rehabilitation, and regular follow-up visits. In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, many previously difficult-to-treat genetic metabolic diseases have been significantly improved.
Treatment needs to be closely monitored for efficacy and adverse reactions, with timely adjustments according to changes in the disease. Multidisciplinary collaboration (MDT) is particularly important for the comprehensive management of pre-diagnosis of carcinoma deficiency. 2.
Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.